Dhruba Acharya

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Adi Idris, Alicia Davis, Aroon Supramaniam et al. · Molecular Therapy · 2021 · 159 citations · Full text

Nanomedicine, Antiviral Therapy, Virology +4

Bupropion and Restless Legs Syndrome: A Randomized Controlled Trial

Max Bayard, Beth A. Bailey, Dhruba Acharya et al. · The Journal of the American Board of Family Medicine · 2011 · 83 citations · Full text

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine

Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris et al. · Science Advances · 2021 · 47 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +17

Drug interaction of promethazine & other non-conventional antimicrobial chemotherapeutic agents.

Anindita Chakrabarty, Dhruba Acharya, Devdatta Suhas Neogi et al. · PubMed · 1989 · 30 citations

Pz-sensitive Strains, Antimicrobial Chemotherapy, Drug Resistance +21

Maternal Determinants of Intra Uterine Growth Retardation : A Case Control Study in Udupi District, Karnataka

Dhruba Acharya, K. Nagraj, Nair Ns et al. · SHILAP Revista de lepidopterología · 2004 · 25 citations · Full text

Fertility, Reproductive Health, Gynecology +24